A contractor working for the CMS has begun the promised audits of Medicare providers and dual-eligible Medicare and Medicaid hospitals that have received federal electronic health-record system incentive payments, the agency confirmed.
The CMS hired Figliozzi & Company of Garden City, N.Y., to perform the audits of providers that have attested to having achieved meaningful use of an EHR under the programs created by the American Recovery and Reinvestment Act of 2009.
Read the full story: http://tinyurl.com/dydnte4
Source: ModernHealthcare.com
The CMS, other than confirming that the audits were under way, declined to elaborate on the extent of the audit program. According to the CMS' website, those being audited will receive a letter from Figliozzi & Company with the CMS logo on the letterhead.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More